MADISON, Wis. and ROME, Dec. 1,
2016 /PRNewswire/ -- Propeller Health, the leading
digital solution for respiratory medicine and Medical International
Research (MIR), a global leader in spirometry, oximetry and
telemedicine, today announced a collaboration to integrate several
of MIR's mobile and clinical spirometers into the Propeller
system.
Lung function measurements provide a physiological perspective
on diseases such as asthma and chronic obstructive pulmonary
disease (COPD). With regular assessment, spirometry can help
patients and physicians determine whether the disease is
progressing, and how patients are responding to treatment. With the
addition of MIR spirometers to its platform, Propeller is the only
commercially marketed respiratory digital health solution to
include FDA cleared inhaler sensors, digital interfaces and truly
mobile spirometers.
Healthcare organizations and pharmaceutical partners using
Propeller can incorporate MIR's spirometers into their clinical and
commercial programs, thereby adding another important signal in the
digital management of patients with asthma and COPD. Data from
these devices will be automatically routed to the Propeller
platform where patients and physicians can evaluate their
status.
"We're excited to partner with MIR to introduce their connected
spirometers to participants in Propeller," said David Van Sickle, CEO. "Periodic assessment can
be helpful in monitoring whether treatment is truly controlling
symptoms and improving quality of life. These next-generation,
mobile spirometers make it possible for patients to better
understand their lung function at home and in the community."
"I am excited about this partnership with Propeller as it offers
our customers a new option in the digital management of respiratory
diseases making available a comprehensive range of sensors. It
happens at the right time now that MIR has launched a new
generation of truly "Smart" spirometers, which provide the
same accuracy of a clinical setting and connect wirelessly to
the Propeller System," commented John Cello, National Sales and
Business Development Manager– MIR USA Inc.
About Propeller
Propeller empowers people with asthma and COPD to live
measurably better lives. In 2010, Propeller set out to modernize
respiratory medicine, help people minimize the impact of asthma and
COPD on their daily lives, and connect them to their physicians,
environment and community. Propeller's information-powered approach
to respiratory management guides physicians and patients to the
optimal path of therapy for each individual. With connected
inhalers, digital interfaces, mobile spirometers and real-time
personalized insights, participants receive personal guidance and
expert direction anytime. Backed by 3M Ventures (NYSE: MMM), SR One
(venture capital arm of GSK), Hikma Ventures (LON: HIK), Safeguard
Scientifics (NYSE: SFE), Social Capital and other investors,
Propeller has been used by patients with asthma or COPD in over 45
commercial programs across the US at major healthcare systems,
payers, employers and other commercial partners. The company has
been recognized as the recipient of the American Telemedicine
Association's 2016 President's Award for Innovation in Remote
Healthcare and as one of the top "Fierce 15" medical device
companies in 2015 by FierceMedicalDevices. For more information
visit: www.propellerhealth.com
About MIR
Since 1993, MIR Italy designs, develops, manufactures and
distributes a highly technological, innovative
and comprehensive range of portable spirometers, oximeters and
solutions for telemedicine, clinical trials and patient
self-monitoring. The cornerstone of MIR spirometry technology is
the FlowMIR disposable turbine. User-friendliness makes all our
devices ideal for both specialists and family doctors. MIR is one
of the most active companies in the world for emerging trends like
wireless real-time health monitoring and truly mobile instruments
for personal care providing fast and intuitive solutions for modern
professionals. MIR continues to strive for advancement of
spirometry technology with many new products on the horizon
reflecting the evolving needs of modern healthcare. Today MIR,
Medical International Research, is present in more than 93
countries worldwide.
Photo - http://photos.prnewswire.com/prnh/20161130/444555
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/propeller-and-mir-announce-license-agreement-and-collaboration-to-integrate-mobile-and-clinic-based-spirometers-into-the-propeller-platform-300371170.html
SOURCE Propeller Health